Blood Cancer Talks

Do you need to get your patient with myeloma into CR prior to autologous transplant? Answers to this and many other key questions in newly diagnosed myeloma with the eloquent and wise @VincentRK on @BloodCancerTalk - wherever you get your podcasts #mmsm #myeloma @rajshekharucms

🎙️ New @BloodCancerTalks episode is live! We sat down with the legendary @VincentRK to discuss newly diagnosed #MultipleMyeloma — diagnosis, risk stratification, induction, when to transplant, and maintenance! share.transistor.fm/s/85832ee7

🔥Now online, our new episode on #ASH25 lymphoma roundup with @DrCarlaCasulo @WilmotCancer! share.transistor.fm/s/97e98f98 @Eddie_Cliff

Our 1st episode of 2026 just dropped! MajesTEC-3 and the Bispecific Revolution! First author @LucianoCostaMD walks us through the nuts and bolts of the data and how BCMA BsAbs will disrupt the treatment paradigm at early relapse! share.transistor.fm/s/7f2b38c0 #ASH25 #mmsm

Join us for the new episode where we dive into management of CMV in immunocompromised patients with hematologic malignancies with @GemmaKReynolds and Dr. Michelle Yong @PeterMacCC! tinyurl.com/5yhr4cyd @Eddie_Cliff @AshKishtagari @rajshekharucms

Tune in to our new episode on International #Myeloma Society 2025 Updates with key abstracts ranging from smoldering myeloma to relapsed/refractory myeloma with @AlGarfall! tinyurl.com/rc764yrh

🎙️ New episode alert! "ctDNA in DLBCL" now live on @BloodCancerTalk. Dive into the latest on circulating tumor DNA as a biomarker for diffuse large B-cell lymphoma monitoring and treatment decisions with experts @AshAlizadeh and @dgermain21! share.transistor.fm/s/3df6104c @Eddie_Cliff

Curious how ctDNA could reshape care for aggressive cancers like #DLBCL? Hear from co-founder Ash Alizadeh on its potential, from advances in detection to breakthrough clinical data. Listen here: bit.ly/4mBkyfr @BloodCancerTalk @rajshekharucms @AshKishtagari @Eddie_Cliff

Don't miss our @icmlugano & @EHA_Hematology lymphoma round-up episode @BloodCancerTalk: Bispecific Bonanza with @AdrianMinson @PeterMacCC SUNMO POLARGO STARGLO R-Pola-Glo LOTIS-7 ...and more Wherever you get your podcasts #lymsm @mike_dickinson1 @rajshekharucms

Tune in to our new episode on EHA and ICML 2025 updates in #lymphoma with @AdrianMinson @PeterMacCC! share.transistor.fm/s/d8c0f8ec Here is a clip of Dr. Minson's take on the Epcor + R-ICE data

🎧 NEW EPISODE ALERT! 🎧 Dive deep into follicular lymphoma management with Dr. Gilles Salles @MSKCancerCenter! From watchful waiting to bispecifics & CAR-T - we cover it all. 🔬 Key trials: RELEVANCE, GALLIUM, InMIND & more Listen now! 🎙️ @Eddie_Cliff share.transistor.fm/s/4fba389f

A real honour to have Prof Gilles Salles @MSKCancerCenter on @BloodCancerTalk for a masterclass on follicular lymphoma. Listen wherever you get your podcasts. @rajshekharucms @mike_dickinson1 @Cure_FL @lymphomahub #lymsm #lymphoma

MIDAS under the Microscope: Check out our special episode unpacking MIDAS trial in newly diagnosed #MultipleMyeloma with @MeeraMohanMD! share.transistor.fm/s/93af17a0

Opinion: Top Studies From EHA 2025 @CancerTherAdvsr cancertherapyadvisor.com/features/top-s…

Missed our @young_eha session on clinical trial appraisal? Check out my short interview with @VJHemOnc on the importance of postprogression care in overall survival assessment Examples: SHINE, TRIANGLE, ZUMA-7 & TRANSFORM. youtube.com/watch?v=pF8B03… #EHA2025 @EHA_Hematology #lymsm

Our new episode on overview of Menin Inhibitors in AML with @Doctor_E_Stein from @MSKCancerCenter just dropped! We had a great discussion on the landscape of menin inhibitors, along with some clinical pearls from Dr. Stein on management! share.transistor.fm/s/f91d6c00 @AshKishtagari

Shamelessly stealing the concept of emergency podcasts from @RestIsPolitics but don’t worry we aren’t talking politics - we talk AQUILA, STARGLO, FDA ODAC Come into the weeds of clinical trials with us Glofitamab-GemOx for R/R DLBCL #starglo #lymsm #ODAC @csoncol @OncoAlert